RecruitingNCT07390331
This study is recruiting. It focuses on depression and currently lists participation information in the United States.
In New YorkDepressionBehavioralOver 18 Years
- Countries
- United States
- Sponsor
- Columbia University
- Condition
- Depression
RecruitingISRCTN67429289
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomSchizophreniaOtherOver 16 Years
- Countries
- United Kingdom
- Sponsor
- Greater Manchester Mental Health NHS Foundation Trust
- Condition
- Schizophrenia
RecruitingNCT07230652
This study is recruiting in China. It focuses on Schizophrenia.
In BeijingSchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
- Countries
- China
- Sponsor
- Luye Pharma Group Ltd.
- Condition
- Schizophrenia
RecruitingISRCTN25163383
This study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomSchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- Clerkenwell Health
- Condition
- Schizophrenia
RecruitingNCT05995782
This study is recruiting in South Korea. It focuses on Schizophrenia.
In SeoulSchizophreniaDrugOver 19 Years
- Countries
- South Korea
- Sponsor
- 1ST Biotherapeutics, Inc.
- Condition
- Schizophrenia
RecruitingNCT07115329
This study is recruiting in the United States. It is testing zelquistinel or Placebo for depression.
Multiple locations, including PhoenixDepressionDrugFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Syndeio Biosciences, Inc
- Condition
- Depression
RecruitingNCT06236880
This study is recruiting in the United Kingdom. It is testing GM-2505 for Depression.
In ManchesterDepressionDrugFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Gilgamesh Pharmaceuticals
- Condition
- Depression
RecruitingISRCTN33909010
This study is recruiting in the United Kingdom, in Bulgaria, in Colombia, .... It focuses on schizophrenia.
In United KingdomSchizophreniaOtherOver 18 Years
- Countries
- United Kingdom, Bulgaria, Colombia, ...
- Sponsor
- Dainippon Sumitomo Pharma America Inc. (USA)
- Condition
- Schizophrenia
RecruitingNCT07592689
This study is recruiting in the United States. It focuses on depression.
Multiple locations, including GilbertDepressionOtherFrom 18 Years to 74 Years
- Countries
- United States
- Sponsor
- Definium Therapeutics US, Inc.
- Condition
- Depression
RecruitingISRCTN44297014
This study is recruiting in the United States, in Colombia, in Germany, .... It focuses on schizophrenia.
In ColombiaSchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- United States, Colombia, Germany, ...
- Sponsor
- Dainippon Sumitomo Pharma America Inc. (USA)
- Condition
- Schizophrenia
RecruitingISRCTN16838597
This study is recruiting in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.
In United KingdomSchizophreniaOtherOver 18 Years
- Countries
- United States, France, United Kingdom, ...
- Sponsor
- Dainippon Sumitomo Pharma America Inc. (USA)
- Condition
- Schizophrenia
RecruitingISRCTN79652741
This study is recruiting in the United Kingdom. It focuses on anxiety.
In United KingdomAnxietyOtherFrom 13 Years to 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Reading (UK)
- Condition
- Anxiety
